Twist Bioscience Corporation (TWST) Earnings History
Net Loss10 years of earnings data (2016–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Twist Bioscience Corporation (TWST) Earnings Overview
As of July 8, 2026, Twist Bioscience Corporation (TWST) reported trailing twelve-month net income of -$81M, reflecting +63.9% year-over-year growth. The company earned $-1.32 per diluted share over the past four quarters, with a net profit margin of -20.6%.
Looking at the long-term picture, TWST's historical earnings data spans multiple years. The company achieved its highest annual net income of -$44M in fiscal 2016.
Twist Bioscience Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ILMN ($853M net income, 19.6% margin), PACB (-$129M net income, -341.5% margin), BEAM (-$65M net income, -57.2% margin), TWST has room to improve margins relative to the peer group. Compare TWST vs ILMN →
TWST Earnings vs Peers
Earnings metrics vs comparable public companies
TWST Historical Earnings Data (2016–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$78M | +62.8% | -$136M | $-1.30 | -20.6% | -36.2% |
| 2024 | -$209M | -2.0% | -$221M | $-3.60 | -66.7% | -70.6% |
| 2023 | -$205M | +6.1% | -$217M | $-3.60 | -83.5% | -88.6% |
| 2022 | -$218M | -43.2% | -$235M | $-4.04 | -107.0% | -115.3% |
| 2021 | -$152M | -8.7% | -$153M | $-3.15 | -114.9% | -115.4% |
| 2020 | -$140M | -30.0% | -$140M | $-3.57 | -155.3% | -155.5% |
| 2019 | -$108M | -51.1% | -$109M | $-3.92 | -198.0% | -200.1% |
| 2018 | -$71M | -20.1% | -$71M | $-2.68 | -280.2% | -277.5% |
| 2017 | -$59M | -34.5% | -$58M | $-3.16 | -550.8% | -543.2% |
| 2016 | -$44M | - | -$44M | $-2.35 | -1943.1% | -1924.0% |
Download Data
Export TWST earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TWST — Frequently Asked Questions
Quick answers to the most common questions about buying TWST stock.
What is TWST earnings per share (EPS)?
TWST trailing twelve-month (TTM) diluted EPS is $-1.32, reflecting +63.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2016 to 2025 is available in the table on this page.
What is Twist Bioscience Corporation's net income?
Twist Bioscience Corporation (TWST) trailing twelve-month net income is $-81M as of 2025. Earnings grew +63.9% year-over-year.
Is TWST profitable?
TWST is not currently profitable on a TTM basis, reporting a net loss of $-81M. Net margin is -20.6%. Investors should monitor for a return to profitability.
What is TWST's earnings growth rate?
TWST compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2016 to 2025.
What are TWST's profit margins?
Twist Bioscience Corporation net profit margin is -20.6%, operating margin is -36.2%, and gross margin is +50.7%. Below-average margins reflect competitive or cost pressures. Return on Equity is -16.4%.
Is TWST growing earnings?
Yes, TWST earnings are accelerating — EPS growth of +63.9% exceeds the 5-year CAGR of N/A. TTM net income reached $-81M. Earnings momentum is strengthening.
What was TWST's best earnings year?
Twist Bioscience Corporation's highest annual net income on record is $-44M, achieved in fiscal year 2016. Earnings history on this page spans 2016 to 2025 and includes all annual and quarterly figures.
What were TWST's earnings last quarter?
TWST's most recent reported quarter was Q2 2026. Net income was $-44M with diluted EPS of $-0.71. For a full breakdown of all quarters, see the quarterly earnings table on this page.